Cargando…

Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) has emerged as one of the most lethal cancers worldwide because of its high refractoriness and multi-drug resistance to existing chemotherapies, which leads to poor patient survival. Novel pharmacological strategies to tackle HCC are based on oral multi-kinase inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devan, Aswathy R., Kumar, Ayana R., Nair, Bhagyalakshmi, Anto, Nikhil Ponnoor, Muraleedharan, Amitha, Mathew, Bijo, Kim, Hoon, Nath, Lekshmi R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308499/ https://www.ncbi.nlm.nih.gov/pubmed/34358082 http://dx.doi.org/10.3390/ph14070656

Ejemplares similares

Translational Phytomedicines against Cancer: Promise and Hurdles
por: Devan, Aswathy R, et al.
Publicado: (2023)

Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
por: Devan, Aswathy R, et al.
Publicado: (2022)

Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence
por: Devan, Aswathy R., et al.
Publicado: (2023)

Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach
por: Nair, Bhagyalakshmi, et al.
Publicado: (2020)

Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
por: Nath, Lekshmi R, et al.
Publicado: (2021)

The Peptidyl-Prolyl cis-trans isomerase, Pin1, associates with Protein Kinase C θ via a critical Phospho-Thr-Pro motif in the V3 regulatory domain
por: Anto, Nikhil Ponnoor, et al.
Publicado: (2023)

Mucus targeting as a plausible approach to improve lung function in COVID-19 patients
por: Kumar, Sarath S., et al.
Publicado: (2021)

Tumor-Specific Growth Factor (TSGF): A Futuristic Tumor Biomarker in Early Diagnosis of Cancer
por: Nair, Bhagyalakshmi, et al.
Publicado: (2023)

2,4-Dihydroxycinnamic acid as spike ACE2 inhibitor and apigenin as RdRp inhibitor in Nimbamritadi Panchatiktam Kashayam against COVID-19: an in silico and in vitro approach
por: Murali, Maneesha, et al.
Publicado: (2022)

Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma
por: Swetha, Mundanattu, et al.
Publicado: (2022)

TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
por: Owen, Allison M., et al.
Publicado: (2021)

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
por: Koyiparambath, Vishal Payyalot, et al.
Publicado: (2021)

Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential
por: Aiswarya, Sreekumar Usha Devi, et al.
Publicado: (2022)

Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential
por: Aiswarya, Sreekumar Usha Devi, et al.
Publicado: (2022)

Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions
por: Mathew, Bijo, et al.
Publicado: (2021)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs
por: Jayaram, Divya Ram, et al.
Publicado: (2021)

Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
por: Rehuman, Nisha Abdul, et al.
Publicado: (2021)

Targeting K-Ras and apoptosis-driven cellular transformation in cancer
por: Godwin, Isha, et al.
Publicado: (2021)

Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
por: Shen, Wanying, et al.
Publicado: (2022)

The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment
por: Keerthana, Chenicheri Kizhakkeveettil, et al.
Publicado: (2023)

Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’
por: Khan, Shahper N., et al.
Publicado: (2016)

Combating multidrug‐resistant Plasmodium falciparum malaria
por: Thu, Aung Myint, et al.
Publicado: (2017)

6,6′-Dihydroxythiobinupharidine (DTBN) Purified from Nuphar lutea Leaves Is an Inhibitor of Protein Kinase C Catalytic Activity
por: Waidha, Kamran, et al.
Publicado: (2021)

Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
por: Koh, Benjamin, et al.
Publicado: (2023)

Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases
por: Pacios, Olga, et al.
Publicado: (2020)

Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry
por: Mathew, Bijo, et al.
Publicado: (2022)

Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections
por: Thimmappa, Pooja Yedehalli, et al.
Publicado: (2023)

Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)

The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: Bertino, Gaetano, et al.
Publicado: (2015)

Impact of Music Distraction on Dental Anxiety in Children Having Intellectual Disability
por: Gowdham, Geethanjali, et al.
Publicado: (2021)

Prospects for the Use of New Technologies to Combat Multidrug-Resistant Bacteria
por: Lima, Renata, et al.
Publicado: (2019)

Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way?
por: Garvey, Mary
Publicado: (2020)

Boosting nanotoxicity to combat multidrug-resistant bacteria in pathophysiological environments
por: Westmeier, Dana, et al.
Publicado: (2020)

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
por: Yadav, Priya, et al.
Publicado: (2022)

What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli
por: Banerjee, Ritu, et al.
Publicado: (2016)

Immunotherapeutic Approaches for Glioblastoma Treatment
por: Yaghi, Nasser K., et al.
Publicado: (2022)

Current Immunotherapeutic Approaches for Malignant Gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: BioMed Research International,
Publicado: (2016)

Development and validation of a prognostic and immunotherapeutically relevant model in hepatocellular carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pfa1dh1j5jf8q4noq914q8iotn